ArticleJournal of medicinal chemistry2022

Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.

Nina Reßing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.